BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 21878675)

  • 21. BCL11B promotes T-cell acute lymphoblastic leukaemia cell survival via the XRCC5/C11ORF21 axis.
    Yu X; Li Y; Yang P; Wang Y; Liu X; Cai L; Lai J; Zhang Y; Zha X; Przybylski GK; Xu L; Li Y
    Clin Transl Med; 2024 Feb; 14(2):e1580. PubMed ID: 38317587
    [No Abstract]   [Full Text] [Related]  

  • 22. Impairment in differentiation and cell cycle of thymocytes by loss of a Bcl11b tumor suppressor allele that contributes to leukemogenesis.
    Go R; Takizawa K; Hirose S; Katsuragi Y; Aoyagi Y; Mishima Y; Kominami R
    Leuk Res; 2012 Aug; 36(8):1035-40. PubMed ID: 22640496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bcl11b mutations identified in murine lymphomas increase the proliferation rate of hematopoietic progenitor cells.
    Karlsson A; Nordigården A; Jönsson JI; Söderkvist P
    BMC Cancer; 2007 Oct; 7():195. PubMed ID: 17941976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and HMGA1.
    Nagel S; Scherr M; Kel A; Hornischer K; Crawford GE; Kaufmann M; Meyer C; Drexler HG; MacLeod RA
    Cancer Res; 2007 Feb; 67(4):1461-71. PubMed ID: 17308084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inactivation of LEF1 in T-cell acute lymphoblastic leukemia.
    Gutierrez A; Sanda T; Ma W; Zhang J; Grebliunaite R; Dahlberg S; Neuberg D; Protopopov A; Winter SS; Larson RS; Borowitz MJ; Silverman LB; Chin L; Hunger SP; Jamieson C; Sallan SE; Look AT
    Blood; 2010 Apr; 115(14):2845-51. PubMed ID: 20124220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Depletion of B cell CLL/Lymphoma 11B Gene Expression Represses Glioma Cell Growth.
    Liao CK; Fang KM; Chai K; Wu CH; Ho CH; Yang CS; Tzeng SF
    Mol Neurobiol; 2016 Aug; 53(6):3528-3539. PubMed ID: 26096706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BCL11B tumor suppressor inhibits HDM2 expression in a p53-dependent manner.
    Obata M; Kominami R; Mishima Y
    Cell Signal; 2012 May; 24(5):1047-52. PubMed ID: 22245141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced level of the BCL11B protein is associated with adult T-cell leukemia/lymphoma.
    Kurosawa N; Fujimoto R; Ozawa T; Itoyama T; Sadamori N; Isobe M
    PLoS One; 2013; 8(1):e55147. PubMed ID: 23383087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genome-wide analyses identify KLF4 as an important negative regulator in T-cell acute lymphoblastic leukemia through directly inhibiting T-cell associated genes.
    Li W; Jiang Z; Li T; Wei X; Zheng Y; Wu D; Yang L; Chen S; Xu B; Zhong M; Jiang J; Hu Y; Su H; Zhang M; Huang X; Geng S; Weng J; Du X; Liu P; Li Y; Liu H; Yao Y; Li P
    Mol Cancer; 2015 Feb; 14():26. PubMed ID: 25644173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The TLX1 oncogene drives aneuploidy in T cell transformation.
    De Keersmaecker K; Real PJ; Gatta GD; Palomero T; Sulis ML; Tosello V; Van Vlierberghe P; Barnes K; Castillo M; Sole X; Hadler M; Lenz J; Aplan PD; Kelliher M; Kee BL; Pandolfi PP; Kappes D; Gounari F; Petrie H; Van der Meulen J; Speleman F; Paietta E; Racevskis J; Wiernik PH; Rowe JM; Soulier J; Avran D; Cavé H; Dastugue N; Raimondi S; Meijerink JP; Cordon-Cardo C; Califano A; Ferrando AA
    Nat Med; 2010 Nov; 16(11):1321-7. PubMed ID: 20972433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unveiling the N-Terminal Homodimerization of BCL11B by Hybrid Solvent Replica-Exchange Simulations.
    Schulig L; Grabarczyk P; Geist N; Delin M; Forkel H; Kulke M; Delcea M; Schmidt CA; Link A
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33807484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bcl11b prevents the intrathymic development of innate CD8 T cells in a cell intrinsic manner.
    Hirose S; Touma M; Go R; Katsuragi Y; Sakuraba Y; Gondo Y; Abe M; Sakimura K; Mishima Y; Kominami R
    Int Immunol; 2015 Apr; 27(4):205-15. PubMed ID: 25422283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multisystem Anomalies in Severe Combined Immunodeficiency with Mutant BCL11B.
    Punwani D; Zhang Y; Yu J; Cowan MJ; Rana S; Kwan A; Adhikari AN; Lizama CO; Mendelsohn BA; Fahl SP; Chellappan A; Srinivasan R; Brenner SE; Wiest DL; Puck JM
    N Engl J Med; 2016 Dec; 375(22):2165-2176. PubMed ID: 27959755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The oncogenetic landscape and clinical impact of
    Dourthe ME; Andrieu GP; Potier A; Balducci E; Guerder J; Simonin M; Courtois L; Petit A; Macintyre E; Boissel N; Baruchel A; Asnafi V
    Haematologica; 2023 Nov; 108(11):3165-3169. PubMed ID: 36891734
    [No Abstract]   [Full Text] [Related]  

  • 35. Genes regulated by BCL11B during T-cell development are enriched for de novo mutations found in schizophrenia patients.
    Fahey L; Donohoe G; Broin PÓ; Morris DW
    Am J Med Genet B Neuropsychiatr Genet; 2020 Sep; 183(6):370-379. PubMed ID: 32729240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down regulation of BCL11B expression inhibits proliferation and induces apoptosis in malignant T cells by BCL11B-935-siRNA.
    Huang X; Chen S; Shen Q; Chen S; Yang L; Grabarczyk P; Przybylski GK; Schmidt CA; Li Y
    Hematology; 2011 Jul; 16(4):236-42. PubMed ID: 21756541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased expression of bcl11b leads to chemoresistance accompanied by G1 accumulation.
    Grabarczyk P; Nähse V; Delin M; Przybylski G; Depke M; Hildebrandt P; Völker U; Schmidt CA
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20824091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter.
    Cismasiu VB; Adamo K; Gecewicz J; Duque J; Lin Q; Avram D
    Oncogene; 2005 Oct; 24(45):6753-64. PubMed ID: 16091750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-7 receptor mutants initiate early T cell precursor leukemia in murine thymocyte progenitors with multipotent potential.
    Treanor LM; Zhou S; Janke L; Churchman ML; Ma Z; Lu T; Chen SC; Mullighan CG; Sorrentino BP
    J Exp Med; 2014 Apr; 211(4):701-13. PubMed ID: 24687960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T-Cell Acute Lymphoblastic Leukemia: Biomarkers and Their Clinical Usefulness.
    Bardelli V; Arniani S; Pierini V; Di Giacomo D; Pierini T; Gorello P; Mecucci C; La Starza R
    Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.